Edinburgh Molecular Imaging Ltd - Product Pipeline Analysis, 2018 Update

Edinburgh Molecular Imaging Ltd - Product Pipeline Analysis, 2018 Update

Summary

Edinburgh Molecular Imaging Ltd (EM Imaging) is a biotechnology company that develops optical molecular imaging technology. The company offers discovery and development of small molecules and peptides. It designs agents to improve the diagnosis and treatment of cancer and lung diseases. EM Imaging’s agents include EMI-137 for CRC Lesion, EMI-200 for inflammation, EMI-300 and 350 for lung infection, EMI-400 for lung fibrosis, EMI-500 for breast cancer, and EMI-600 for single pulmonary nodules. The company develops optical imaging platform which shows the increased fluorescent signal from the optical agents on target engagement in a diseased patient. EM Imaging is headquartered in Edinburgh, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Edinburgh Molecular Imaging Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



List of Tables 3
List of Figures 3
Edinburgh Molecular Imaging Ltd Company Overview 4
Edinburgh Molecular Imaging Ltd Company Snapshot 4
Edinburgh Molecular Imaging Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Edinburgh Molecular Imaging Ltd – Pipeline Analysis Overview 7
Edinburgh Molecular Imaging Ltd - Key Facts 7
Edinburgh Molecular Imaging Ltd - Major Products and Services 8
Edinburgh Molecular Imaging Ltd Pipeline Products by Development Stage 9
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status 11
Edinburgh Molecular Imaging Ltd Pipeline Products Overview 12
EMI-137 12
EMI-137 Product Overview 12
EMI-137 Clinical Trial 13
EMI-200 14
EMI-200 Product Overview 14
EMI-300/350 15
EMI-300/350 Product Overview 15
EMI-400 16
EMI-400 Product Overview 16
EMI-500 17
EMI-500 Product Overview 17
EMI-600 18
EMI-600 Product Overview 18
Edinburgh Molecular Imaging Ltd - Key Competitors 19
Edinburgh Molecular Imaging Ltd - Key Employees 20
Edinburgh Molecular Imaging Ltd - Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Edinburgh Molecular Imaging Ltd, Recent Developments 22
Sep 20, 2017: Edinburgh Molecular Imaging Commences Phase II European Cancer Trial 22
Mar 09, 2016: Edinburgh Molecular Imaging Awarded Innovate UK Grant To Qualify The Role Of EMI-137 In Colorectal Cancer Lesion Detection 22
Appendix 24
Methodology 24
About GlobalData 27
Contact Us 27
Disclaimer 27


List Of Tables

List of Tables
Edinburgh Molecular Imaging Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Edinburgh Molecular Imaging Ltd Pipeline Products by Equipment Type 5
Edinburgh Molecular Imaging Ltd Pipeline Products by Indication 6
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status 6
Edinburgh Molecular Imaging Ltd, Key Facts 7
Edinburgh Molecular Imaging Ltd, Major Products and Services 8
Edinburgh Molecular Imaging Ltd Number of Pipeline Products by Development Stage 9
Edinburgh Molecular Imaging Ltd Pipeline Products Summary by Development Stage 10
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status 11
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials Summary 11
EMI-137 - Product Status 12
EMI-137 - Product Description 12
EMI-137 - A Phase IIb, Open Label Study for the Detection of Dysplastic Colorectal Polyps during Colonoscopy after EMI-137 Injection in Patients with High Risk of Colorectal Cancer 13
EMI-200 - Product Status 14
EMI-200 - Product Description 14
EMI-300/350 - Product Status 15
EMI-300/350 - Product Description 15
EMI-400 - Product Status 16
EMI-400 - Product Description 16
EMI-500 - Product Status 17
EMI-500 - Product Description 17
EMI-600 - Product Status 18
EMI-600 - Product Description 18
Edinburgh Molecular Imaging Ltd, Key Employees 20
Glossary 26


List Of Figures

List of Figures
Edinburgh Molecular Imaging Ltd Pipeline Products by Equipment Type 5
Edinburgh Molecular Imaging Ltd Pipeline Products by Development Stage 9
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status 11


Edinburgh Molecular Imaging Ltd - Product Pipeline Analysis, 2018 Update

Edinburgh Molecular Imaging Ltd (EM Imaging) is a biotechnology company that develops optical molecular imaging technology.

USD 750 View Report

EDINBURGH WORLDWIDE INVESTMENT TST Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

EDINBURGH WORLDWIDE INVESTMENT TST Company Profile is a detailed strategic and analytical report on EDINBURGH WORLDWIDE INVESTMENT TST. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

ABT Molecular Imaging Inc - Medical Equipment - Deals and Alliances Profile

ABT Molecular Imaging Inc (ABT) is a medical imaging company engaged in the development of biomarker generator systems and related accessories. Its technology platform BG-75, a biomarker generator produces unit

USD 250 View Report

Edinburgh Molecular Imaging Ltd - Product Pipeline Analysis, 2017 Update

Edinburgh Molecular Imaging Ltd (EM Imaging) is a clinical phase biotechnology company that develops optical molecular imaging technology. It is involved in the discovery and development of small molecules and

USD 750 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available